Cite

HARVARD Citation

    Hannestad, J. et al. (2020). Safety and tolerability of GRF6019 in mild‐to‐moderate Alzheimer's disease dementia. Alzheimer's & dementia. 6 (1), p. n/a. [Online]. 
  
Back to record